Cite
APA Citation
Othus, M., Thomas, I., Wang, X., Ariti, C., Mehta, P., Sydenham, M., Hills, R. K., Burnett, A. K., Nand, S., Assouline, S., Michaelis, L. C., Erba, H. P., Russell, N., Kerr, K. F., Walter, R. B., & Dennis, M. (2023). early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG. Leukemia & lymphoma, 64(1), 250–252. http://access.bl.uk/ark:/81055/vdc_100177563858.0x000036